Send InquiryInquiry
Call Us
+919173178176
Contact Us For Help
Home » Products » Anticancer Medicines » Erlotinib Tablets IP 100mg

Erlotinib Tablets IP 100mg

Erlotinib Tablets IP 100mg
Erlotinib Tablets IP 100mg
Send Inquiry
Product Code : AC001
Brand Name : Erlonat 100
Price And Quantity
  • Minimum Order Quantity
  • 1
  • Unit of Measure
  • Box/Boxes
  • Price
  • 145 USD ($)
Product Specifications
  • Drug Type
  • General Medicines
  • Formulations Type
  • General Drugs
  • Formulations Form
  • Tablets
  • Physical Form
  • Tablets
  • Treatments & Functions
  • lung cancer or pancreatic cancer
  • Gender/Age Group
  • Suitable For All Ages
Product Description

Erlotinib is a cancer medicine that interferes with the growth of cancer cells and slows their spread in the body.

Erlotinib is used to treat non-small cell lung cancer or pancreatic cancer that has spread to other parts of the body (metastatic).

Erlotinib is usually given after other cancer medicines have been tried without success.

Erlotinib may also be used for purposes not listed in this medication guide.



Trade Information
  • Payment Terms
  • Cash in Advance (CID), Cheque
  • Supply Ability
  • 1000 Per Day
  • Delivery Time
  • 10 Days
  • Packaging Details
  • 30 tablets in a bottle
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

ACTIZA PHARMACEUTICAL PRIVATE LIMITED

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

+ Add Attachment
<< Back
X


We are looking forward to foreign inquiries. 
Get In Touch
ACTIZA PHARMACEUTICAL PRIVATE LIMITED
Address
  • 309, Royal Square, Utaran, Surat - 394105, Gujarat, India
Phone
  • Phone :+918068094455
Key Personnel
  • Mr Milan Sojitra (BDM)
  • Mobile :+918068094455
Send Inquiry Send Inquiry
Send SMS Send SMS
   
Call Me Free Call Me Free
Quick Links
  • Product Showcase
ACTIZA PHARMACEUTICAL All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.